Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT07321912
Recruiting
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Phase 2 · United States · 3 sites
Registry update: 6 Oct 2026
NCT07629960
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Phase 1/2 · Spain, United States · 16 sites
Registry update: 21 Sept 2026
NCT07492823
Recruiting
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Not applicable · Austria · 1 site
Registry update: 7 Oct 2026
NCT06735820
Recruiting
Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST
Phase 1/2 · United States · 2 sites
Registry update: 27 Jul 2026
NCT07584499
Recruiting
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Phase 1 · China · 1 site
Registry update: 13 May 2026
2025-521702-18-00
Recruiting
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Phase 1 · Germany, Denmark, Spain, France, Portugal · 10 sites
Registry update: 15 Sept 2026
NCT06465199
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/2 · United States · 14 sites
Registry update: 3 Sept 2026
NCT07613723
Recruiting
A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
Phase 1 · United Kingdom · 2 sites
Registry update: 4 Sept 2026
NCT07628634
Recruiting
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Early phase 1 · United States · 1 site
Registry update: 31 Jul 2026
NCT07458347
Recruiting
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 · United States · 9 sites
Registry update: 15 Oct 2026
NCT07459283
Recruiting
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Early phase 1 · China · 1 site
Registry update: 4 Sept 2026
NCT07685405
Recruiting
Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas
Not applicable · Italy · 1 site
Registry update: 6 Jul 2026
NCT07283731
Recruiting
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 2 Nov 2026
NCT07261657
Recruiting
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Early phase 1 · United States · 1 site
Registry update: 27 Aug 2026
NCT06898203
Recruiting
Precision Imaging to Evaluate Kaposi Sarcoma
Not applicable · Kenya, Uganda · 2 sites
Registry update: 21 Sept 2026
NCT07308886
Recruiting
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
Phase 2 · United States · 1 site
Registry update: 25 Aug 2026
NCT07297979
Recruiting
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Phase 1 · Australia, United States · 13 sites
Registry update: 29 Oct 2026
NCT07548177
Recruiting
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Phase 2 · China · 15 sites
Registry update: 23 Apr 2026
NCT07298083
Recruiting
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
Not applicable · United States · 1 site
Registry update: 18 Sept 2026
NCT07552467
Recruiting
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Not applicable · China · 1 site
Registry update: 27 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.